Quantification of peri-operative myocardial infarction after coronary artery bypass surgery.

1. Steinhubl SR, Berger PB, Mann 3rd JT et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411–20. [Erratum JAMA 2003; 289: 987]. 2. Eriksson P. Long-term clopidogrel therapy after percutaneous coronary intervention in PCI–CURE and CREDO: the ‘‘Emperor’s New Clothes’’ revisited. Eur Heart J 2004;25: 720–2. 3. The clopidogrel in unstable angina to present recurrent events trial with acute coronary syndromes without ST-segment elevation. New Engl J Med 2001; 345: 494–502 [Erratum New Engl J Med 2001; 345: 1716]. 4. Yusuf S, Mehta SR, Zhao F et al. Clopidogrel in unstable angina to prevent recurrent events trial investigators. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003;107:966–72. 5. Peters RJ, Mehta SR, Fox KA et al. Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation 2003;108:1682–7. 6. Mehta SR, Yusuf S, Peters RJG et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI–CURE study. Lancet 2001;358:527–33. 7. Diener H-C, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebocontrolled trial. Lancet 2004;364:331–7.